nach oben

Current Sleep Medicine Reports

Erschienen in:

05.05.2023

Insomnia and Hypoglossal Nerve Stimulation

verfasst von: Tarek Dabboussi, Shalini Manchanda, Noah P. Parker, Yelena Chernyak, Stephanie M. Stahl

Erschienen in: Current Sleep Medicine Reports | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Hypoglossal nerve stimulation (HGNS) use is rapidly increasing, yet factors remain that limit its overall adherence and treatment outcomes. This review explores the prevalence of insomnia in patients with HGNS, the effects of insomnia on HGNS treatment outcomes, and possible management options.

Recent Findings

Insomnia is present in approximately 26–57% of patients using HGNS with the highest prevalence in veterans. Insomnia may be a barrier to HGNS use and optimal treatment benefit. In those with insomnia, subjective benefit in daytime sleepiness, perceived sleep quality, and overall satisfaction with HGNS is less than in those without insomnia. The current data on optimal treatment of insomnia in those with HGNS is limited; however, CBT-I and pharmacologic therapy may have benefit. Additionally, the use of HGNS may improve insomnia in some patients.

Summary

Insomnia is highly prevalent in patients using HGNS and may negatively affect HGNS use and improvement in daytime symptoms. Screening for and treatment of insomnia in all patients prior to HGNS implantation and activation are recommended.

Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–76.CrossRefPubMed

Strollo PJ Jr, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014;370(2):139–49. https://doi.org/10.1056/NEJMoa1308659.CrossRefPubMed

Thaler E, Schwab R, Maurer J, Soose R, Larsen C, Stevens S, et al. Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. Laryngoscope. 2020;130(5):1333–8. https://doi.org/10.1002/lary.28286.CrossRefPubMed

Bonnet MH, Arand DL. Hyperarousal and insomnia: state of the science. Sleep Med Rev. 2010;14(1):9–15. https://doi.org/10.1016/j.smrv.2009.05.002.CrossRefPubMed

Zhang Y, Ren R, Lei F, Zhou J, Zhang J, Wing YK, et al. Worldwide and regional prevalence rates of co-occurrence of insomnia and insomnia symptoms with obstructive sleep apnea: A systematic review and meta-analysis. Sleep Med Rev. 2019;45:1–17. https://doi.org/10.1016/j.smrv.2019.01.004.CrossRefPubMed

6•.

. Luyster FS, Buysse DJ, Strollo PJ Jr. Comorbid insomnia and obstructive sleep apnea: challenges for clinical practice and research. J Clin Sleep Med. 2010;6(2):196–204. This article highlights hyperarousal in insomnia and how this can affect OSA treatment.CrossRefPubMedPubMedCentral

Sweetman A, Lack L, Bastien C. Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials. Brain Sci. 2019;9(12):371. https://doi.org/10.3390/brainsci9120371.CrossRefPubMedPubMedCentral

Krakow B, Melendrez D, Ferreira E, Clark J, Warner TD, Sisley B, et al. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest. 2001;120(6):1923–9. https://doi.org/10.1378/chest.120.6.1923.CrossRefPubMed

Wallace DM, Sawyer AM, Shafazand S. Comorbid insomnia symptoms predict lower 6-month adherence to CPAP in US veterans with obstructive sleep apnea. Sleep Breath. 2018;22(1):5–15. https://doi.org/10.1007/s11325-017-1605-3.CrossRefPubMed

10•.

Jomha M, Dabboussi T, Parker NP, Manchanda S, Chernyak Y, Stahl SM. Prevalence of insomnia and restless legs syndrome in patients with upper airway stimulation therapy and effects on treatment outcomes. Sleep Med. 2022;98:121–6. https://doi.org/10.1016/j.sleep.2022.06.016. This is the only article that reports the prevalence of chronic insomnia in people with HGNS. Objective sleep study parameters, HGNS usage, and subjective benefit are also compared.CrossRefPubMed

11•.

Dhanda Patil R, Hong MP, Ishman SL. Hypoglossal nerve stimulation in veterans with comorbid insomnia and sleep apnea. Otolaryngol Head Neck Surg. 2021;164(6):1345–53. https://doi.org/10.1177/0194599820982638. This article reports a high prevalence of insomnia in veterans using HGNS and the effects of insomnia.CrossRefPubMed

12.

Wallace DM, Wohlgemuth WK. 0558—Upper airway stimulation in US veterans with obstructive sleep apnea with and without insomnia: A preliminary study. Sleep. 2019;42(Supplement 1):A222–3.CrossRef

13••.

Steffen A, Baptista P, Ebner EM, Jeschke S, König IR, Bruchhage KL. Insomnia affects patient-reported outcome in sleep apnea treated with hypoglossal nerve stimulation. Laryngoscope Investig Otolaryngol. 2022;7(3):877–84. https://doi.org/10.1002/lio2.761. This is the largest currently available article evaluating the effects of insomnia in those with HGNS, showing a decrease in improvement in daytime sleepiness and sleep-related quality of life.CrossRefPubMedPubMedCentral

14.

Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. https://doi.org/10.1053/smrv.2002.0186.CrossRefPubMed

15.

Calem M, Bisla J, Begum A, Dewey M, Bebbington PE, Brugha T, et al. Increased prevalence of insomnia and changes in hypnotics use in England over 15 years: analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity Surveys. Sleep. 2012;35(3):377–84. https://doi.org/10.5665/sleep.1700.CrossRefPubMedPubMedCentral

16.

Stelzer FG, Garcia E, Schorr F, Barea LM, Barros HT. Prevalence of chronic insomnia in patients with obstructive sleep apnea. Braz J Psychiatry. 2021;43(4):370–5. https://doi.org/10.1590/1516-4446-2019-0814.CrossRefPubMed

17.

Gilbert KS, Kark SM, Gehrman P, Bogdanova Y. Sleep disturbances, TBI and PTSD: Implications for treatment and recovery. Clin Psychol Rev. 2015;40:195–212. https://doi.org/10.1016/j.cpr.2015.05.008.CrossRefPubMedPubMedCentral

18.

Folmer RL, Smith CJ, Boudreau EA, Hickok AW, Totten AM, Kaul B, et al. Prevalence and management of sleep disorders in the Veterans Health Administration. Sleep Med Rev. 2020;54:101358. https://doi.org/10.1016/j.smrv.2020.101358.CrossRefPubMed

19.

Fung CH, Martin JL, Dzierzewski JM, Jouldjian S, Josephson K, Park M, et al. Prevalence and symptoms of occult sleep disordered breathing among older veterans with insomnia. J Clin Sleep Med. 2013;9(11):1173–8. https://doi.org/10.5664/jcsm.3162.CrossRefPubMedPubMedCentral

20.

Wallace DM, Vargas SS, Schwartz SJ, Aloia MS, Shafazand S. Determinants of continuous positive airway pressure adherence in a sleep clinic cohort of South Florida Hispanic veterans. Sleep Breath. 2013;17(1):351–63. https://doi.org/10.1007/s11325-012-0702-6.CrossRefPubMed

21.

Pieh C, Bach M, Popp R, Jara C, Crönlein T, Hajak G, et al. Insomnia symptoms influence CPAP compliance. Sleep Breath. 2013;17(1):99–104. https://doi.org/10.1007/s11325-012-0655-9.CrossRefPubMed

22.

•. Pascoe M, Wang L, Aylor J, Mehra R, Kominsky A, Foldvary-Schaefer N, et al. Association of hypoglossal nerve stimulation with improvements in long-term, patient-reported outcomes and comparison with positive airway pressure for patients with obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg. 2022;148(1):61–9. https://doi.org/10.1001/jamaoto.2021.2245. This article compares improvements in insomnia, daytime sleepiness, and quality of life in those with HGNS to those with PAP therapy.CrossRefPubMed

23••.

Luyster FS, Ni Q, Lee K, Harrison C, Ramprasad VH, Soose RJ, et al. Factors affecting obstructive sleep apnea patients' use of upper airway stimulation treatment. J Clin Sleep Med. 2022;18(9):2207–15. https://doi.org/10.5664/jcsm.10086. High vs low users of HGNS are compared in this study with a high prevalence of insomnia in the low-users group.CrossRefPubMed

24.

Rosenthal ME, Lyons MM, Schweller J, Yildiz VO, Chio EG, Khan MS. Association between anxiety, depression, and emotional distress and hypoglossal nerve stimulator adherence. Sleep Breath. 2022;26(1):141–7. https://doi.org/10.1007/s11325-021-02366-4.CrossRefPubMed

25•.

Stahl SM, Manchanda S, Parker N, Chernyak Y. Insomnia and Upper Airway Stimulation Therapy Benefit and Adherence: A Case Series [published online ahead of print, 2022 Jun 6]. J Clin Psychol Med Settings. 2022; https://doi.org/10.1007/s10880-022-09885-6. This is the only currently available article that discusses management of insomnia in patients with HGNS and also highlights the importance of decreasing the arousal index for overall insomnia and OSA management.

26.

Björnsdóttir E, Janson C, Sigurdsson JF, Gehrman P, Perlis M, Juliusson S, et al. Symptoms of insomnia among patients with obstructive sleep apnea before and after two years of positive airway pressure treatment. Sleep. 2013;36(12):1901–9. https://doi.org/10.5665/sleep.3226.CrossRefPubMedPubMedCentral

27.

Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.CrossRefPubMedPubMedCentral

28.

Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(3):191–204. https://doi.org/10.7326/M14-2841.CrossRefPubMed

29.

Sweetman A, Lack L, McEvoy RD, Antic NA, Smith S, Chai-Coetzer CL, et al. Cognitive behavioural therapy for insomnia reduces sleep apnoea severity: a randomised controlled trial. ERJ Open Res. 2020;6(2):00161–2020. https://doi.org/10.1183/23120541.00161-2020.CrossRefPubMedPubMedCentral

30.

Rosenberg R, Roach JM, Scharf M, Amato DA. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. Sleep Med. 2007;8(5):464–70. https://doi.org/10.1016/j.sleep.2006.10.007.CrossRefPubMed

31.

Lettieri CJ, Shah AA, Holley AB, Kelly WF, Chang AS, Roop SA. Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. Ann Intern Med. 2009;151(10):696–702. https://doi.org/10.7326/0003-4819-151-10-200911170-00006.CrossRefPubMed

32.

Sweetman A, Lack L, Catcheside PG, Antic NA, Smith S, Chai-Coetzer CL, et al. Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial. Sleep. 2019;42(12):zsz178. https://doi.org/10.1093/sleep/zsz178.CrossRefPubMed

Titel: Insomnia and Hypoglossal Nerve Stimulation
verfasst von: Tarek Dabboussi
Shalini Manchanda
Noah P. Parker
Yelena Chernyak
Stephanie M. Stahl
Publikationsdatum: 05.05.2023
Verlag: Springer International Publishing
Erschienen in: Current Sleep Medicine Reports / Ausgabe 3/2023
Elektronische ISSN: 2198-6401
DOI: https://doi.org/10.1007/s40675-023-00255-8

Error Propagation from Sleep Stage Classification to Derived Sleep Parameters in Machine Learning on Data from Wearables

Open Access

The Insomnia-Suicide Link Across the Life Cycle: a Review

Too Sour to be True? Tart Cherries (Prunus cerasus) and Sleep: a Systematic Review and Meta-analysis

Open Access

Digital Health Interventions for Insomnia: Turning Promise into Reality

Co-morbid Insomnia and Sleep Apnoea (COMISA): Latest Research from an Emerging Field

Open Access

Valerian for Insomnia on Subjective and Objective Sleep Parameters: a Meta-analysis of Randomized Controlled Trials

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

17.04.2025
AAN-Jahrestagung 2025
Kongressbericht

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

Therapiestopp bei älteren MS-Kranken kann sich lohnen

17.04.2025
AAN-Jahrestagung 2025
Nachrichten

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Schadet Schichtarbeit dem Gehirn?

17.04.2025
AAN-Jahrestagung 2025
Kongressbericht

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Obstruktive Schlafapnoe: Das steht abseits von CPAP auf dem Plan

17.04.2025
DGP 2025
Kongressbericht

Die obstruktive Schlafapnoe kann durch verschiedene Verfahren behandelt werden wie Lagetherapie und chirurgische Interventionen. Eine medikamentöse Therapie kommt zwar (noch) nicht infrage. Auf dem Pneumologie-Kongress wurden aber erste vielversprechende Ansätze präsentiert.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Insomnia and Hypoglossal Nerve Stimulation